In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
A study published this week found that Black Medicare beneficiaries with early-stage NSCLC remain significantly less likely than White beneficiaries to receive curative treatment, largely because of ...
Lung cancer is now the leading cause of cancer deaths in the United States, claiming more lives than several other major ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...
EVERY day without a dedicated PhilHealth Z Benefit Package for lung cancer means more Filipino families face delayed ...
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.
A procedure that can help spot lung cancer early is now available at a hospital, saving patients long trips out of a county.
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results